[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100634759":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":25,"locations":34,"responsibleParty":52,"collaborators":20,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":59,"acronym":60,"eligibilityCriteria":61,"healthyVolunteers":57,"sex":62,"minAge":63,"maxAge":20,"enrollmentInfo":64,"targetDuration":20,"studyType":67,"phases":68,"briefSummary":70,"conditions":71,"keywords":20,"overallStatus":37,"whyStopped":20,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"University of Michigan","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Dynamic Standing Desk in People with Parkinsons","EXPERIMENTAL","Up to 12 4-hour sessions with the dynamic standing desk completed in the span of 6 weeks.",[13],"Device: Dynamic Standing Desk",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","Dynamic Standing Desk","Participants will stand at the desk for 4 hours per session. During each session, the desk will move to prompt the participant to take small steps. Participants will take breaks as needed. Each participant will complete up to 12 sessions in the span of 6 weeks.",[9],null,[22],{"name":23,"affiliation":5,"role":24},"Chatkaew Pongmala, PhD","PRINCIPAL_INVESTIGATOR",[26,31],{"name":27,"role":28,"phone":29,"phoneExt":20,"email":30},"Miriam Van Emde Boas, DPT","CONTACT","734-936-1174","bohnenmi@med.umich.edu",{"name":23,"role":28,"phone":32,"phoneExt":20,"email":33},"734-936-0111","pchatkae@med.umich.edu",[35],{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Domino's Farms","RECRUITING","Ann Arbor","Michigan","48105","United States","US",{"type":44,"coordinates":45},"Point",[46,47],-83.74088,42.27756,{"lat":47,"lon":46},[50],{"name":51,"role":28,"phone":29,"phoneExt":20,"email":30},"Miriam Bohnen, DPT",{"type":24,"investigatorFullName":53,"investigatorTitle":54,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"Chatkaew Pongmala","Research Investigator","100634759","phase-1-a-pilot-study-of-in-lab-dynamic-standing-in-parkinsons-disease-100634759",false,"NCT07543861","A Pilot Study of In-lab Dynamic Standing in Parkinson's Disease","FOGSTAND","Inclusion Criteria:\n\n* Diagnosis of Parkinson's Disease\n\nExclusion Criteria:\n\n* Inability to stand or walk without an assistive device\n* History of symptoms in stance that preclude safe and comfortable participation, such as dizziness and lightheadedness, orthostasis, severe symptomatic leg or back musculoskeletal pain, or medication side effects\n* Any other history of medical or psychiatric comorbidity, precluding safe participation in the project.\n* History of symptomatic cardiovascular or pulmonary disease\n* History of active rheumatic arthritis\n* History of stroke or other neurologic conditions with significant residual sensorimotor deficits\n* History of disabling chronic pain syndrome requiring narcotic analgesics\n* Evidence of dementia (Mini Mental State Exam (or Montreal Cognitive Assessment test) \\\u003C24 and significant impairment in activities of daily living)\n* Venous ulcerative stasis or severe varicosities.\n* Pregnancy as determined by urine pregnancy test prior to DXA procedure in women of childbearing potential.","ALL","50 Years",{"count":65,"type":66},5,"ESTIMATED","INTERVENTIONAL",[69],"PHASE1","This research is studying the use of a new type of standing desk in a small number of people to learn about the user experience for people with Parkinson's disease. 12 4-hour sessions will be performed to test the primary hypothesis that dynamic standing improves gait function compared to static standing and control sitting. This study has 2 phases. Phase 1 will be an open-label study and Phase 2 will be an in-lab randomized controlled trial pilot study. This is phase 1 of the study.",[72],"Parkinson Disease","2026-08-11",{"date":75,"type":76},"2026-08-14","ACTUAL",{"date":78,"type":76},"2026-05-15",{"date":80,"type":66},"2027-03",{"name":5,"class":6},1]